SEPTInvestingStart Free

VRAX EFFECT: SEC filing

Virax Biolabs Group Ltd

Filed with the SEC on · accession 9999999995-26-002878

VRAX filed a EFFECT (effect) with the SEC on Sep 3, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +0.6% by the first close after the filing.

Summary of the filing

Virax Biolabs Group Ltd filed an EFFECT notice with the SEC, indicating that a previously filed registration statement has become effective.

For details, click here →

Key details

FilerVirax Biolabs Group Ltd

How VRAX stock reacted

Close before

$2.54

Sep 2, 2026

First close after

+0.59%

$2.56

5 trading days

+11.98%

$2.85

Since filing

-75.93%

$0.61

✦ Ask GOAX AI about this filing — what it means for VRAX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for VRAX?

Click here

Frequently asked questions

What did VRAX file with the SEC on Sep 3, 2026?

VRAX filed a EFFECT (SEC filing). Virax Biolabs Group Ltd filed an EFFECT notice with the SEC, indicating that a previously filed registration statement has become effective.

How do I read a EFFECT?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A EFFECT (effect): A report the company filed with the SEC (the US market regulator).

How did VRAX stock react to this filing?

VRAX closed at $2.54 before the filing and $2.56 on Sep 3, 2026 (+0.59%). Five trading days later: $2.85 (+11.98%).

Other VRAX SEC filings

Get alerts when VRAX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
VRAX overviewVRAX analysisVRAX newsLatest SEC filings